89 related articles for article (PubMed ID: 1916231)
1. Production of monoclonal antibody to Clostridium difficile toxin A which neutralizes enterotoxicity but not haemagglutination activity.
Kamiya S; Yamakawa K; Meng XQ; Ogura H; Nakamura S
FEMS Microbiol Lett; 1991 Jul; 65(3):311-5. PubMed ID: 1916231
[TBL] [Abstract][Full Text] [Related]
2. [Preparation and characterization of monoclonal antibody against Clostridium difficile toxin A].
Fu SW; Zhou DY; Lai ZS; Xue J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):376-8. PubMed ID: 15193243
[TBL] [Abstract][Full Text] [Related]
3. Production and characterisation of monoclonal antibodies to Verotoxins 1 and 2 from Escherichia coli of serotype O 157:H7.
Padhye VV; Zhao T; Doyle MP
J Med Microbiol; 1989 Nov; 30(3):219-26. PubMed ID: 2479749
[TBL] [Abstract][Full Text] [Related]
4. Preparation and preliminary application of monoclonal antibodies to the receptor binding region of Clostridium difficile toxin B.
Chen W; Liu WE; Li YM; Luo S; Zhong YM
Mol Med Rep; 2015 Nov; 12(5):7712-20. PubMed ID: 26459027
[TBL] [Abstract][Full Text] [Related]
5. Detection of Clostridium difficile toxin A by reversed passive latex agglutination.
Toma C; Nakamura S; Kamiya S; Nakasone N; Iwanaga M
Microbiol Immunol; 1999; 43(8):737-42. PubMed ID: 10524790
[TBL] [Abstract][Full Text] [Related]
6. Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies.
Lyerly DM; Phelps CJ; Toth J; Wilkins TD
Infect Immun; 1986 Oct; 54(1):70-6. PubMed ID: 2428753
[TBL] [Abstract][Full Text] [Related]
7. Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters.
Babcock GJ; Broering TJ; Hernandez HJ; Mandell RB; Donahue K; Boatright N; Stack AM; Lowy I; Graziano R; Molrine D; Ambrosino DM; Thomas WD
Infect Immun; 2006 Nov; 74(11):6339-47. PubMed ID: 16966409
[TBL] [Abstract][Full Text] [Related]
8. Development of an ELISA kit using monoclonal antibody to Clostridium difficile toxin A.
Fu SW; Zhang YL; Zhou DY
World J Gastroenterol; 2004 Sep; 10(18):2747-9. PubMed ID: 15309733
[TBL] [Abstract][Full Text] [Related]
9. Determination of the reactivities and cross-reactivities of monoclonal antibodies against staphylococcal enterotoxin A by indirect ELISA and immunoblot including a semiautomated electrophoresis system.
Goyache J; Orden JA; Blanco JL; Domenech A; Hernandez J; Suarez G; Gomez-Lucia E
Lett Appl Microbiol; 1992 May; 14(5):217-20. PubMed ID: 1368221
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterisation of intracellular toxin A of Clostridium difficile.
Meng XQ; Kamiya S; Yamakawa K; Ogura H; Nakamura S
J Med Microbiol; 1993 Jan; 38(1):69-73. PubMed ID: 8418298
[TBL] [Abstract][Full Text] [Related]
11. Immunochemical and structural similarities in toxin A and toxin B of Clostridium difficile shown by binding to monoclonal antibodies.
Rothman SW; Gentry MK; Brown JE; Foret DA; Stone MJ; Strickler MP
Toxicon; 1988; 26(6):583-97. PubMed ID: 2459808
[TBL] [Abstract][Full Text] [Related]
12. Characterization of six murine monoclonal antibodies specific for toxin B of Clostridium difficile.
Coughlin RT; Annunziato M; Roberson J; Marciani DJ
Hybridoma; 1994 Apr; 13(2):147-52. PubMed ID: 8050780
[TBL] [Abstract][Full Text] [Related]
13. A Combination of Three Fully Human Toxin A- and Toxin B-Specific Monoclonal Antibodies Protects against Challenge with Highly Virulent Epidemic Strains of Clostridium difficile in the Hamster Model.
Anosova NG; Cole LE; Li L; Zhang J; Brown AM; Mundle S; Zhang J; Ray S; Ma F; Garrone P; Bertraminelli N; Kleanthous H; Anderson SF
Clin Vaccine Immunol; 2015 Jul; 22(7):711-25. PubMed ID: 25924765
[TBL] [Abstract][Full Text] [Related]
14. Neutralization of hemolytic and mouse lethal activities of C. perfringens alpha-toxin need simultaneous blockade of two epitopes by monoclonal antibodies.
Schoepe H; Wieler LH; Bauerfeind R; Schlapp T; Potschka H; Hehnen HR; Baljer G
Microb Pathog; 1997 Jul; 23(1):1-10. PubMed ID: 9250775
[TBL] [Abstract][Full Text] [Related]
15. Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies.
Downes FP; Barrett TJ; Green JH; Aloisio CH; Spika JS; Strockbine NA; Wachsmuth IK
Infect Immun; 1988 Aug; 56(8):1926-33. PubMed ID: 3294179
[TBL] [Abstract][Full Text] [Related]
16. Haemagglutination activity of toxigenic and non-toxigenic strains of Clostridium difficile.
Meng XQ; Yamakawa K; Ogura H; Nakamura S
FEMS Microbiol Lett; 1994 May; 118(1-2):141-4. PubMed ID: 8013869
[TBL] [Abstract][Full Text] [Related]
17. Production of monoclonal antibodies against Clostridium difficile cytotoxin using immunosorbent binding bioassay procedure.
Depitre C; L'Haridon RM; Lyerly DM; Barroso LA; Wilkins TD; Andremont A; Corthier G
Toxicon; 1993 Feb; 31(2):181-6. PubMed ID: 8456445
[TBL] [Abstract][Full Text] [Related]
18. A non-haemagglutinating form of Clostridium difficile toxin A.
Kamiya S; Borriello SP
J Med Microbiol; 1992 Mar; 36(3):190-7. PubMed ID: 1548692
[TBL] [Abstract][Full Text] [Related]
19. Immunological comparison of intracellular toxin A and extracellular toxin A from Clostridium difficile.
Meng XQ; Yamakawa K; Ogura H; Nakamura S
Jpn J Med Sci Biol; 1993 Feb; 46(1):51-6. PubMed ID: 8230809
[TBL] [Abstract][Full Text] [Related]
20. Production and characterisation of monoclonal antibodies specific for staphylococcal enterotoxin B.
Lin YS; Largen MT; Newcomb JR; Rogers TJ
J Med Microbiol; 1988 Dec; 27(4):263-70. PubMed ID: 3199425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]